Colchicine in coronary disease: another renaissance of an ancient drug.

Fiolet, Aernoud T L; Thompson, Peter L; Mosterd, Arend

Fiolet, Aernoud T L; Thompson, Peter L; Mosterd, Arend.

Fiolet ATL; Department of Cardiology, University Medical Centre Utrecht, Utrecht, The Netherlands.
Thompson PL; Netherlands Heart Institute, Utrecht, The Netherlands.
Mosterd A; Department of Cardiology, Meander Medical Centre, P.O. Box 1502, 3800 BM Amersfoort, The Netherlands.

Cardiovasc Res ; 117(1): e4-e6, 2021 01 01.

Article in English | MEDLINE | ID: covidwho-1177292

Subject(s)

Anti-Inflammatory Agents/therapeutic use; Cardiovascular Agents/therapeutic use; Cardiovascular Diseases/drug therapy; Colchicine/therapeutic use; Drug Repositioning; Inflammation Mediators/antagonists & inhibitors; Anti-Inflammatory Agents/adverse effects; Cardiovascular Agents/adverse effects; Cardiovascular Diseases/metabolism; Cardiovascular Diseases/mortality; Cardiovascular Diseases/physiopathology; Colchicine/adverse effects; Humans; Inflammation Mediators/metabolism

Keywords

Clinical trials; Colchicine; Coronary disease; Inflammation

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Cardiovascular Agents / Cardiovascular Diseases / Colchicine / Inflammation Mediators / Drug Repositioning / Anti-Inflammatory Agents Type of study: Prognostic study Limits: Humans Language: English Journal: Cardiovasc Res Year: 2021 Document Type: Article Affiliation country: Cvr

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google